CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Translumina startet die globale randomisierte kontrollierte Studie „SPARX", um die Evidenzbasis für medikamentenbeschichtete Ballons bei komplexen Koronarerkrankungen zu erweitern

Read the original article

Published by PR Newswire Pharma on October 13, 2026 4:05 AM

Read Original